Compare MLSS & NSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MLSS | NSPR |
|---|---|---|
| Founded | 1989 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 42.6M | 38.9M |
| IPO Year | 1996 | 2009 |
| Metric | MLSS | NSPR |
|---|---|---|
| Price | $0.30 | $0.45 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 3 |
| Target Price | $1.25 | ★ $3.33 |
| AVG Volume (30 Days) | 82.4K | ★ 172.5K |
| Earning Date | 08-13-2026 | 11-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $8,973,982.00 | $2,310,000.00 |
| Revenue This Year | $11.14 | $9.14 |
| Revenue Next Year | $13.80 | $105.44 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 3.99 | N/A |
| 52 Week Low | $0.22 | $0.43 |
| 52 Week High | $0.58 | $2.41 |
| Indicator | MLSS | NSPR |
|---|---|---|
| Relative Strength Index (RSI) | 24.46 | 26.81 |
| Support Level | $0.24 | N/A |
| Resistance Level | $0.31 | $0.72 |
| Average True Range (ATR) | 0.03 | 0.07 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 5.71 | 11.15 |
Milestone Scientific Inc develops and commercializes proprietary computer-controlled drug delivery systems designed to enhance the safety, precision, and patient experience associated with subcutaneous injections and fluid aspiration procedures. The company's core technology platform, Dynamic Pressure Sensing (DPS) Technology, controls flow rate and measures pressure at the needle tip in real time. DPS Technology is incorporated into both the company's dental and medical products and supports clinical applications, including local anesthesia delivery, epidural space identification in regional anesthesia procedures, and intra-articular joint injections. It operates in two segments: Dental, which markets and sells its dental products, and Medical, markets and sells its medical products.
InspireMD Inc is a United States-based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System. It generates the majority of the revenue from the sales of CGuard EPS, which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The Company has one operating and reporting segment that develops, manufactures, and markets products for the treatment of carotid artery disease and other vascular diseases, including the Company's proprietary CGuard stent platform.